Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH RecommandationsPar SFTH5 mars 2024
Recommendations for clinical laboratory testing for protein S deficiency SSC plasma coagulation inhibitors RecommandationsPar SFTH5 mars 2024
Recommendations for the measurement of thrombin generation SSC Lupus Anticoagulant RecommandationsPar SFTH5 mars 2024
« Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function SSC Platelet Physiology » RecommandationsPar SFTH5 mars 2024
« Diagnosis and management of severe congenital protein C deficiency SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders SSC Platelet Physiology » RecommandationsPar SFTH5 mars 2024
« Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome SSC Lupus Anticoagulant » RecommandationsPar SFTH5 mars 2024
« Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Assays to quantify fibrinolysis: strengths and limitations SSC fibrinolysis » RecommandationsPar SFTH5 mars 2024